These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 1758537

  • 1. Increases in circulating level of platelet-activating factor lag behind transient neutropenia during hemodialysis with cuprophane membranes.
    Sakaguchi K, Morimoto S, Chen YH, Nakamoto Y, Ogihara T.
    Nephron; 1991; 59(3):455-60. PubMed ID: 1758537
    [Abstract] [Full Text] [Related]

  • 2. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C, Afentakis N, Nomikos T, Dinas C, Stavropoulos-Giokas C, Antonopoulou S.
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Patient reactions and granulocyte degranulation during hemodialysis with cuprophane and polycarbonate membranes. A double-blind study.
    Danielson BG, Hällgren R, Venge P.
    Blood Purif; 1986 May; 4(1-3):147-50. PubMed ID: 3524607
    [Abstract] [Full Text] [Related]

  • 9. Hemodialysis-associated platelet activation and thrombocytopenia.
    Hakim RM, Schafer AI.
    Am J Med; 1985 Apr; 78(4):575-80. PubMed ID: 3885730
    [Abstract] [Full Text] [Related]

  • 10. The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis.
    Kabasakal C, Mir S, Gousseinov A, Cura A, Betin N, Coker I.
    Turk J Pediatr; 1998 Apr; 40(3):413-20. PubMed ID: 9763906
    [Abstract] [Full Text] [Related]

  • 11. Effect of dialyzer geometry during hemodialysis with cuprophane membranes.
    Taylor JE, McLaren M, Mactier RA, Henderson IS, Stewart WK, Belch JJ.
    Kidney Int; 1992 Aug; 42(2):442-7. PubMed ID: 1405328
    [Abstract] [Full Text] [Related]

  • 12. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane].
    Pak K, Kobira S, Tomoyoshi T, Nishimura N.
    Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143
    [Abstract] [Full Text] [Related]

  • 13. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
    Varela MP, Kimmel PL, Phillips TM, Mishkin GJ, Lew SQ, Bosch JP.
    Blood Purif; 2001 Sep; 19(4):370-9. PubMed ID: 11574733
    [Abstract] [Full Text] [Related]

  • 14. Dietary salt, blood pressure and circulating levels of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in patients with essential hypertension.
    Masugi F, Sakaguchi K, Saeki S, Imaoka M, Ogihara T.
    J Lipid Mediat; 1989 Sep; 1(6):341-8. PubMed ID: 2519902
    [Abstract] [Full Text] [Related]

  • 15. Leucocyte occlusion of cuprophane membranes as a cause of reduced hemodialysis efficiency.
    Dodd NJ, Parsons V, Weston MJ.
    Int J Artif Organs; 1982 Jul; 5(4):275-6. PubMed ID: 7118290
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neutrophil reactive oxygen species production during hemodialysis: role of activated platelet adhesion to neutrophils through P-selectin.
    Bonomini M, Stuard S, Carreno MP, Settefrati N, Santarelli P, Haeffner-Cavaillon N, Albertazzi A.
    Nephron; 1997 Jul; 75(4):402-11. PubMed ID: 9127326
    [Abstract] [Full Text] [Related]

  • 18. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis.
    Sirolli V, Strizzi L, Di Stante S, Robuffo I, Procopio A, Bonomini M.
    Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316
    [Abstract] [Full Text] [Related]

  • 19. Hemodialysis-associated neutropenia and hypoxemia: the effect of dialyzer membrane materials.
    Hakim RM, Lowrie EG.
    Nephron; 1982 Sep; 32(1):32-9. PubMed ID: 6817150
    [Abstract] [Full Text] [Related]

  • 20. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis.
    Gastaldello K, Husson C, Wens R, Vanherweghem JL, Tielemans C.
    Nephrol Dial Transplant; 2000 Oct; 15(10):1638-46. PubMed ID: 11007834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.